Jefferies Financial Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,500
| Closed | -$498K | – | 1327 |
|
|
2025
Q1 | $498K | Buy |
+4,500
| New | +$498K | ﹤0.01% | 839 |
|
|
2024
Q4 | – | Sell |
-4,390
| Closed | -$506K | – | 1375 |
|
|
2024
Q3 | $506K | Sell |
4,390
-390
| -8% | -$44.9K | ﹤0.01% | 738 |
|
|
2024
Q2 | $658K | Sell |
4,780
-1,155
| -19% | -$159K | 0.01% | 663 |
|
|
2024
Q1 | $819K | Sell |
5,935
-691
| -10% | -$95.3K | 0.01% | 649 |
|
|
2023
Q4 | $873K | Buy |
+6,626
| New | +$873K | 0.01% | 683 |
|
|
2023
Q1 | – | Sell |
-14,511
| Closed | -$1.73M | – | 1325 |
|
|
2022
Q4 | $1.73M | Buy |
+14,511
| New | +$1.73M | 0.01% | 398 |
|